Treating Trichotillomania: Cognitive-Behavioral Therapy for Hairpulling and Related Problems

Martin E. Franklin · David F. Tolin

2007년 9월 · Springer Science & Business Media

eBook

210

페이지

검증되지 않은 평점과 리뷰입니다. 자세히 알아보기

eBook 정보

The first and perhaps most important step in writing a treatment manual for use in clinical practice is to clearly explicate the logic of how the treatment, and hence the book, should be organized. Accordingly, our goal in this section is to lay out the structure of cognitive-behavioral therapy (CBT) for trichotillomania (TTM) and other body-focused impulse control disorders, clearly explaining critical decisions such as the chosen sequence of techniques or whether a given technique is considered a core component or a module to be used in some but not all cases. The structure of this particular book is influenced by the work of experts who have gone before us in pioneering CBT for TTM, and is also informed by over a decade of our own clinical work and research on TTM across the developmental spectrum. We are indebted to those who developed this approach to treatment and also to those who built the extant literature on the psychopathology of TTM and related disorders. These clinicians and researchers did so in order to help alle- ate the suffering of those afflicted with these conditions, and we endeavor to f- low in their footsteps in continuing this important work.

저자 정보

Martin E. Franklin, Ph.D., Associate Professor of Clinical Psychology in Psychiatry and Clinical Director of the Center for the Treatment and Study of Anxiety at the University of Pennsylvania School of Medicine, received his Ph.D. in clinical psychology from the University of Rhode Island in 1993. Dr. Franklin joined the Center's faculty in 1992 upon completion of his clinical internship at the Medical College of Pennsylvania/Eastern Pennsylvania Psychiatric Institute. His scholarly publications include scientific articles and book chapters on the treatment of adult and pediatric OCD, social phobia, trichotillomania, PTSD, and readiness for behavior change. He was a member of the Expert Consensus Panel for Obsessive Compulsive Disorder that assisted with the development of treatment guidelines for adult and pediatric OCD. Dr. Franklin is a co-investigator and clinical supervisor on the Center's ongoing NIMH-funded randomized controlled trials in pediatric OCD, adult OCD, and social phobia.

David F. Tolin, Ph.D., is the founder and Director of the Anxiety Disorders Center at The Institute of Living. He is also Assistant Professor of Psychiatry at the University of Connecticut School of Medicine. Dr. Tolin received his Ph.D. from the University of Arkansas, and completed a predoctoral internship at Tufts University School of Medicine/VA Medical Center, Boston. Dr. Tolin's research and clinical interests include cognitive-behavioral therapy for anxiety disorders in adults and children, and cognitive processes that underlie anxiety disorders, particularly obsessive-compulsive disorder, posttraumatic stress disorder, and panic disorder. He is the recipient of the award for Distinguished Contribution to the Science of Psychology from the Connecticut Psychological Association, and an Early Career Award from the Anxiety Disorders Special Interest Group of the Association for Advancement of Behavior Therapy. He is a Fellow of the Council for Scientific Medicine and Mental Health.

Dr. Tolin is the author of over 90 journal articles and book chapters, and over 140 research presentations to national and international organizations. Dr. Tolin is principal investigator on the National Institute of Mental Health (NIMH)-funded studies "Stepped Care for Obsessive-Compulsive Disorder" and "Neural Mechanisms of Compulsive Hoarding," and co-investigator on the NIMH-funded studies "Psychopathology of Compulsive Hoarding" (principal investigator: R. Frost), "Treatment of Compulsive Hoarding" (principal investigator: G. Steketee), and "Screening for GAD among Frail Elderly" (principal investigator: G. Diefenbach). He has served as principal investigator on several industry-sponsored clinical trials of experimental medications. Dr. Tolin has been interviewed for The New York Times and the Associated Press, and has been a recurrent guest on The Today Show, Good Morning America and The Oprah Winfrey Show.